Selected data models

You must log in to select data models for download or further analysis.

7 Search results.
Relevance Rating New first Old first

Interferon-alfa-2b after 5-FU in Metastatic Gastrointestinal, Kidney, or Lung Cancer, NCT01658813 - Eligibility

- 3/12/20 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
5-FU Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01658813

Eligibility Colorectal Neoplasms NCT02450656

- 3/6/19 - 1 form, 2 itemgroups, 19 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Colorectal, Non-small Cell Lung and Pancreatic Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02450656

Eligibility Colorectal Cancer NCT00684801

- 12/27/17 - 1 form, 1 itemgroup, 15 items, 1 language
Itemgroup: Criteria
Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers; ODM derived from: https://clinicaltrials.gov/show/NCT00684801

Eligibility Cancer NCT00756847

- 11/10/17 - 1 form, 2 itemgroups, 20 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00756847

Eligibility Diabetes Type 1 Prevention NCT01030861

- 10/7/18 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"; ODM derived from: https://clinicaltrials.gov/show/NCT01030861 Collaborating Parties: National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Center for Research Resources (NCRR) Juvenile Diabetes Research Foundation American Diabetes Association

Eligibility Hepatitis A NCT00197002

- 9/16/16 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Immune Response & Safety of a Hepatitis A Vaccine Given Together With a Pneumococcal Vaccine in Healthy Children 15 m of Age; ODM derived from: https://clinicaltrials.gov/show/NCT00197002

Eligibility Portopulmonary Hypertension NCT01028651

- 8/29/18 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01028651

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial